Immunogenicity and Pharmacokinetics of Guselkumab Among Patients with Moderate-to-Severe Psoriasis in VOYAGE-1 and VOYAGE-2.
A ArmstrongKilian EyerichCurdin ConradY ZhuY-W YangM MillerY YouY K ShenP FoleyChristopher Ernest Maitland GriffithsBruce E StroberPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)